Detailed Narrative
Economic Growth Engine & IRX
Ingersoll Rand's economic growth engine and IRX framework are credited for outperformance in 2024, delivering double-digit adjusted EPS growth and strong free cash flow despite dynamic global markets. The company emphasizes its employee ownership model and sustainability leadership, ranking #1 in its industry in the Dow Jones Best-in-Class Indices and CDP's A List. This model has created approximately $700 million of incremental wealth for employees.
Strategic Transformation & M&A
Since the 2020 merger, Ingersoll Rand has transformed into a growth compounder, divesting cyclical businesses and reinvesting $5.4 billion into accretive acquisitions in high-growth sustainable end markets. This strategy nearly doubled its total addressable market in three years, expanding it by approximately $12 billion in 2024. The company acquired $625 million in annualized revenue from 18 acquisitions in 2024 at less than 14x pre-synergy adjusted EBITDA multiple.
M&A Funnel & Outlook
The M&A funnel remains robust with over 200 active targets and 7 additional transactions at the LOI stage. The company expects to acquire an additional 400-500 basis points of annualized inorganic revenue in 2025, incremental to current guidance, maintaining a disciplined approach with an average sub-10x pre-synergy adjusted EBITDA purchase multiple for recent deals and a mid-teens ROIC target by year three. Six companies, including channel acquisitions, have closed since the Q3 earnings call.
China Dynamics & Regional Focus
China's organic orders were softer than anticipated in Q4 due to timing of📎 large orders, but book-to-bill was approximately 1, indicating some stability. Excluding China, organic orders grew low single digits. The company is pivoting investments to underpenetrated markets like Latin America, Middle East, India, and APAC (excluding China), which showed robust growth. Momentum is encouraging in countries like Vietnam and Australia, reflecting a strategic shift away from China.
PST Segment Performance & ILC Dover
PST's Q4 adjusted EBITDA margin declined to 27.6% due to lower volumes in ILC Dover's Aerospace and Defense business and organic volume declines from China. However, the ILC Dover life science business grew revenue double digits. A multiyear agreement for the legacy spacesuit business ($150M+) was secured in December, incorporated into 2025 guidance, and is expected to contribute to margin recovery in PST, with the segment targeting a return to the 30% EBITDA margin range in 2025.
Demand Signals & Project Elongation
MQL activity remained strong, up low double digits in Q4 and full-year 2024. The long-cycle pipeline also grew low double digits for the full year. While decision-making remains elongated, customer conversation activity has increased, suggesting potential conversion of projects in 2025, with no significant project cancellations. The company is actively working with customers, even deploying engineers to help unblock large projects.
Pricing Strategy & Cost Mitigation
The 2025 organic growth guidance includes 75% from price and 25% from volume, with pricing expected to accelerate in the second half due to planned mid-year actions. The company has tiered mitigation plans for potential tariffs, leveraging its in-region for-region manufacturing and global supply chain. Domestic U.S. purchases from China represent a single-digit percentage of COGS, and the company expects to mitigate impacts through pricing actions, similar to its successful navigation of tariffs in 2021.